1. Home
  2. IOVA vs TRNS Comparison

IOVA vs TRNS Comparison

Compare IOVA & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • TRNS
  • Stock Information
  • Founded
  • IOVA 2007
  • TRNS 1964
  • Country
  • IOVA United States
  • TRNS United States
  • Employees
  • IOVA N/A
  • TRNS N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • TRNS Electrical Products
  • Sector
  • IOVA Health Care
  • TRNS Industrials
  • Exchange
  • IOVA Nasdaq
  • TRNS Nasdaq
  • Market Cap
  • IOVA 975.1M
  • TRNS 842.7M
  • IPO Year
  • IOVA N/A
  • TRNS N/A
  • Fundamental
  • Price
  • IOVA $2.30
  • TRNS $71.91
  • Analyst Decision
  • IOVA Buy
  • TRNS Buy
  • Analyst Count
  • IOVA 11
  • TRNS 4
  • Target Price
  • IOVA $11.90
  • TRNS $108.67
  • AVG Volume (30 Days)
  • IOVA 10.8M
  • TRNS 110.2K
  • Earning Date
  • IOVA 11-06-2025
  • TRNS 10-27-2025
  • Dividend Yield
  • IOVA N/A
  • TRNS N/A
  • EPS Growth
  • IOVA N/A
  • TRNS N/A
  • EPS
  • IOVA N/A
  • TRNS 1.44
  • Revenue
  • IOVA $241,525,000.00
  • TRNS $288,138,000.00
  • Revenue This Year
  • IOVA $67.40
  • TRNS $16.67
  • Revenue Next Year
  • IOVA $56.32
  • TRNS $9.14
  • P/E Ratio
  • IOVA N/A
  • TRNS $50.04
  • Revenue Growth
  • IOVA 636.99
  • TRNS 8.49
  • 52 Week Low
  • IOVA $1.64
  • TRNS $67.56
  • 52 Week High
  • IOVA $12.51
  • TRNS $133.72
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 50.67
  • TRNS 33.55
  • Support Level
  • IOVA N/A
  • TRNS $75.30
  • Resistance Level
  • IOVA $2.46
  • TRNS $79.89
  • Average True Range (ATR)
  • IOVA 0.14
  • TRNS 3.08
  • MACD
  • IOVA -0.09
  • TRNS -1.12
  • Stochastic Oscillator
  • IOVA 92.00
  • TRNS 2.57

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About TRNS Transcat Inc.

Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.

Share on Social Networks: